Phyllis Schlafly

The abortion industry racks up profits by dumping expensive procedural complications on hospitals, legitimate physicians and the public. Many abortionists lack staff privileges at local hospitals, so when women having abortion complications go to an emergency room, the enormous costs are shifted to others.

Missouri ended some of that cost-shifting in 2005 by prohibiting abortions unless the provider has hospital privileges within 30 miles. As a result, one of its only three abortion clinics closed shop, presumably because its abortionist lacked staff privileges at a local hospital to handle complications and abortions in Missouri then declined.

Last month Mississippi became the second state to prohibit abortions unless performed by a physician who has privileges at a local hospital. That should stop the shifting of the costs of abortion complications to hospitals and the public, and some news reports claim that the only abortion clinic in Mississippi may even close.

Several other states have ineffective versions of this law, with loopholes allowing abortionists to continue to avoid taking care of their complications. Unlike the 1990s, when effective state legislation reduced the number of abortions, many pro-life bills today are diluted to ineffectiveness before passage, and in the rare instance that they are effective, state officials often fail to defend them against court challenges.

Meanwhile, the abortion industry has begun performing abortions through "telemedicine" without the abortionist even being present to see his patient and handle immediate complications. Under this procedure, the physician, who may be thousands of miles away, pretends to "examine" a woman from afar.

The abortionist communicates with the woman by modern technology, tells her to take an abortion drug, and then leaves her on her own to expel the baby later into a toilet. If there are complications, the abortionist is nowhere nearby for further treatment or surgery.

The abortion drug commonly called RU-486 was approved by the Food and Drug Administration only on the condition that it be administered under the supervision of a physician able "to provide surgical intervention in cases" with complications. The FDA is part of the Obama administration, so it is unlikely to take action against any abortion clinic that misuses this drug to do more abortions.

Phyllis Schlafly

Phyllis Schlafly is a national leader of the pro-family movement, a nationally syndicated columnist and author of Feminist Fantasies.
TOWNHALL DAILY: Be the first to read Phyllis Schlafly‘s column. Sign up today and receive daily lineup delivered each morning to your inbox.